open access

Vol 80, No 3 (2022)
Short communication
Published online: 2022-01-13
Get Citation

Prevalence of heart rhythm disorders in patients with end-stage heart failure referred to qualification for heart transplantation

Adam Wojtaszczyk12, Mariusz Gąsior1, Bożena Szyguła-Jurkiewicz1, Mateusz Tajstra1
DOI: 10.33963/KP.a2022.0010
·
Pubmed: 35023568
·
Kardiol Pol 2022;80(3):339-341.
Affiliations
  1. 3rd Department of Cardiology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Silesian Center for Heart Diseases, Zabrze, Poland
  2. Department of Electrocardiology, Medical University of Lodz, Łódź, Poland

open access

Vol 80, No 3 (2022)
Short communication
Published online: 2022-01-13

Abstract

Not available

Abstract

Not available
Get Citation
Supp./Additional Files (1)
Supplementary material
Download
105KB
About this article
Title

Prevalence of heart rhythm disorders in patients with end-stage heart failure referred to qualification for heart transplantation

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 80, No 3 (2022)

Article type

Short communication

Pages

339-341

Published online

2022-01-13

Page views

347

Article views/downloads

135

DOI

10.33963/KP.a2022.0010

Pubmed

35023568

Bibliographic record

Kardiol Pol 2022;80(3):339-341.

Authors

Adam Wojtaszczyk
Mariusz Gąsior
Bożena Szyguła-Jurkiewicz
Mateusz Tajstra

References (15)
  1. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021; 42(36): 3599–3726.
  2. Andrew J, Macdonald P. Latest developments in heart transplantation: a review. Clin Ther. 2015; 37(10): 2234–2241.
  3. Paluszkiewicz L, Kukulski T, Zembala M, et al. The role of long-term mechanical circulatory support in the treatment of end-stage heart failure. Kardiol Pol. 2019; 77(3): 331–340.
  4. AlTurki A, Proietti R, Dawas A, et al. Catheter ablation for atrial fibrillation in heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials. BMC Cardiovasc Disord. 2019; 19(1): 18.
  5. Pedersen CT, Kay GN, Kalman J, et al. EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Europace. 2014; 16(9): 1257–1283.
  6. Anter E, Jessup M, Callans DJ. Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation. 2009; 119(18): 2516–2525.
  7. Ziff OJ, Carter PR, McGowan J, et al. The interplay between atrial fibrillation and heart failure on long-term mortality and length of stay: Insights from the, United Kingdom ACALM registry. Int J Cardiol. 2018; 252: 117–121.
  8. Wijesurendra RS, Casadei B. Atrial fibrillation: effects beyond the atrium? Cardiovasc Res. 2015; 105(3): 238–247.
  9. Range FT, Schäfers M, Acil T, et al. Impaired myocardial perfusion and perfusion reserve associated with increased coronary resistance in persistent idiopathic atrial fibrillation. Eur Heart J. 2007; 28(18): 2223–2230.
  10. Freestone B, Chong AY, Nuttall S, et al. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels. Thromb Res. 2008; 122(1): 85–90.
  11. Lim HS, Willoughby SR, Schultz C, et al. Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm. J Am Coll Cardiol. 2013; 61(8): 852–860.
  12. Gadula-Gacek E, Tajstra M, Niedziela J, et al. Characteristics and Outcomes in Patients With Electrical Storm. Am J Cardiol. 2019; 123(10): 1637–1642.
  13. Cleland JG, Abraham WT, Linde C, et al. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure. Eur Heart J. 2013; 34(46): 3547–3556.
  14. Gąsior M, Pyka Ł, Gorol J, et al. COnteMporary Modalities In Treatment of Heart Failure: a report from the COMMIT-HF registry. Kardiol Pol. 2016; 74(6): 523–528.
  15. Tajstra M, Sokal A, Gadula-Gacek E, et al. Remote Supervision to Decrease Hospitalization Rate (RESULT) study in patients with implanted cardioverter-defibrillator. Europace. 2020; 22(5): 769–776.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Sp. z o.o. VM Group Sp.k., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl